Prospects for applying synthetic biology to toxicology: Future opportunities and current limitations for the repurposing of cytochrome P450 systems

Chemical Research in Toxicology

Volumn 30, Issue 1, 2016, Pages 453-468

  Behrendorff, James B Y H ^a   Gillam, Elizabeth M J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; IMMOBILIZED ENZYME;

BIOCATALYSIS; BIOREACTOR; BIOREMEDIATION; BIOSYNTHESIS; DRUG DEVELOPMENT; DRUG INDUSTRY; HEALTH; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; REVIEW; SYNTHETIC BIOLOGY; TOXICOLOGY; GENETIC PROCEDURES;

BIOCATALYSIS; BIODEGRADATION, ENVIRONMENTAL; BIOSENSING TECHNIQUES; DRUG INDUSTRY; HUMANS; SYNTHETIC BIOLOGY; TOXICOLOGY;

EID: 85015136158     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/acs.chemrestox.6b00396     Document Type: Review

References (177)

1. Rollie, S., Mangold, M., and Sundmacher, K. (2012) Designing biological systems: Systems Engineering meets Synthetic Biology. Chem. Eng. Sci. 69, 1-29.
2. Schmidt, M., and Pei, L. (2011) Synthetic toxicology: Where engineering meets biology and toxicology. Toxicol. Sci. 120, S204-S224.
3. Brian, W. R., and Srivastava, P. K., Umbenhauer, D. R., Lloyd, R. S., and Guengerich, F. P. (1989) Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemistry 28, 4993-4999.
4. Wrighton, S. A., and Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, F. P., and Raucy, J. L., Molowa, D. T., and VandenBranden, M. (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38, 207-213.
5. Renaud, J.-P., Cullin, C., Pompon, D., Beaune, P., and Mansuy, D. (1990) Expression of human liver cytochrome P450 IIIA4 in yeast: a functional model for the hepatic enzyme. Eur. J. Biochem. 194, 889-896.
6. Guengerich, F. P., and Brian, W. R., Sari, M.-A., and Ross, J. T. (1991) Expression of mammalian cytochrome P450 enzymes using yeast-based vectors. Methods Enzymol. 206, 130-145.
7. Larson, J. R., and Coon, M. J., and Porter, T. D. (1991) Alcohol-inducible cytochrome P-450IIE1 lacking the hydrophobic NH2-terminal segment retains catalytic activity and is membrane-bound when expressed in Escherichia coli. J. Biol. Chem. 266, 7321-7324.
8. Fisher, C. W., and Caudle, D. L., Martinwixtrom, C., Quattrochi, L. C., and Tukey, R. H., Waterman, M. R., and Estabrook, R. W. (1992) High level expression of functional human cytochrome P450 1A2 in Escherichia coli. FASEB J. 6, 759-764.
9. Winters, D. K., and Cederbaum, A. I. (1992) Expression of a catalytically active human cytochrome P-450 2E1 in Escherichia coli. Biochim. Biophys. Acta, Gen. Subj. 1156, 43-49.
10. Gillam, E. M. J., Baba, T., Kim, B.-R., Ohmori, S., and Guengerich, F. P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123-131.
11. Pernecky, S. J., and Larson, J. R., Philpot, R. M., and Coon, M. J. (1993) Expression of truncated forms of liver microsomal P450 cytochromes 2B4 and 2E1 in Escherichia coli: influence of NH2-terminal region on localization in cytosol and membranes. Proc. Natl. Acad. Sci. U. S. A. 90, 2651-2655.
12. Sandhu, P., Baba, T., and Guengerich, F. P. (1993) Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch. Biochem. Biophys. 306, 443-450.
13. Gillam, E. M. J., Guo, Z., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys. 312, 59-66.
14. Guo, Z., Gillam, E. M. J., Ohmori, S., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys. 312, 436-446.
15. Gillam, E. M. J., and Guo, Z. Y., Martin, M. V., Jenkins, C. M., and Guengerich, F. P. (1995) Expression of cytochrome P450 2D6 in Escherichia coli: Purification, and spectral and catalytic characterization. Arch. Biochem. Biophys. 319, 540-550.
16. Kempf, A., and Zanger, U. M., and Meyer, U. A. (1995) Truncated human P450 2D6: expression in Escherichia coli: Ni2+-chelate affinity purification, and characterization of solubility and aggregation. Arch. Biochem. Biophys. 321, 277-288.
17. Pritchard, M. P., Ossetian, R., Li, D. N., and Henderson, C. J., Burchell, B., Wolf, C. R., and Friedberg, T. (1997) A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: Expression of CYP3A4, CYP2A6, and CYP2E1. Arch. Biochem. Biophys. 345, 342-354.
18. Peyronneau, M. A., and Renaud, J. P., Truan, G., Urban, P., Pompon, D., and Mansuy, D. (1992) Optimization of yeast-expressed human liver cytochrome-P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5. Eur. J. Biochem. 207, 109-116.
19. Parikh, A., Gillam, E. M. J., and Guengerich, F. P. (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15, 784-788.
20. Fujita, K., Iwata, H., Kushida, H., Suzuki, A., Nakamura, K., Konno, Y., and Kamataki, T. (1997) Simultaneous expression of human P450 and human NADPH-P450 reductase in E-coli: Extremely high activity to metabolize drugs. FASEB J. 11, A791-A791.
21. Blake, J. A. R., Pritchard, M., Ding, S., Smith, G. C. M., Burchell, B., Wolf, C. R., and Friedberg, T. (1996) Coexpression of a human P450 (CYP3A4) and P450 reductase generated a highly functional monooxygenase system in Escherichia coli. FEBS Lett. 397, 210-214.
22. Guengerich, F. P., Parikh, A., Johnson, E. F., and Richardson, T. H., VonWachenfeldt, C., Cosme, J., Jung, F., and Strassburg, C. P., Manns, M. P., Tukey, R. H., Pritchard, M., Fournel Gigleux, S., and Burchell, B. (1997) Heterologous expression of human drug-metabolizing enzymes. Drug Metab. Dispos. 25, 1234-1241.
23. Yun, C. H., and Yim, S. K., Kim, D. H., and Ahn, T. (2006) Functional expression of human cytochrome P450 enzymes in Escherichia coli. Curr. Drug Metab. 7, 411-429.
24. Gillam, E. M. J. (1998) Human cytochrome P450 enzymes expressed in bacteria: Reagents to probe molecular interactions in toxicology. Clin. Exp. Pharmacol. Physiol. 25, 877-886.
25. Rushmore, T. H., and Reider, P. J., Slaughter, D., Assang, C., and Shou, M. (2000) Bioreactor systems in drug metabolism: Synthesis of cytochrome P450-generated metabolites. Metab. Eng. 2, 115-125.
26. Vail, R. B., and Homann, M. J., Hanna, I., and Zaks, A. (2005) Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli. J. Ind. Microbiol. Biotechnol. 32, 67-74.
27. Hunter, D. J. B., Behrendorff, J. B. Y. H., Johnston, W. A., Hayes, P. Y., Huang, W., Bonn, B., Hayes, M. A., De Voss, J. J., and Gillam, E. M. J. (2011) Facile production of minor metabolites for drug development using a CYP3A shuffled library. Metab. Eng. 13, 682-693.
28. Munro, A. W., and Leys, D. G., McLean, K. J., Marshall, K. R., Ost, T. W. B., Daff, S., Miles, C. S., and Chapman, S. K., Lysek, D. A., Moser, C. C., Page, C. C., and Dutton, P. L. (2002) P450BM3: the very model of a modern flavocytochrome. Trends Biochem. Sci. 27, 250-257.
29. Otey, C. R., Landwehr, M., Endelman, J. B., Hiraga, K., and Bloom, J. D., and Arnold, F. H. (2006) Structure-guided recombination creates an artificial family of cytochromes P450. PLoS Biol. 4, e112.
30. Sawayama, A. M., Chen, M. M. Y., Kulanthaivel, P., Kuo, M. S., Hemmerle, H., and Arnold, F. H. (2009) A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. Chem. - Eur. J. 15, 11723-11729.
31. Damsten, M. C., van Vugt-Lussenburg, B. M. A., Zeldenthuis, T., de Vlieger, J. S. B., Commandeur, J. N. M., and Vermeulen, N. P. E. (2008) Application of drug metabolising mutants of cytochrome P450BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. Chem.-Biol. Interact. 171, 96-107.
32. Boerma, J. S., Vermeulen, N. P. E., and Commandeur, J. N. M. (2011) Application of CYP102A1M11H as a tool for the generation of protein adducts of reactive drug metabolites. Chem. Res. Toxicol. 24, 1263-1274.
33. van Vugt-Lussenburg, B. M. A., Stjernschantz, E., Lastdrager, J., Oostenbrink, C., Vermeulen, N. P. E., and Commandeur, J. N. M. (2007) Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. J. Med. Chem. 50, 455-461.
34. Kim, D. H., and Kim, K. H., Kim, D., Jung, H. C., and Pan, J. G., Chi, Y. T., Ahn, T., and Yun, C. H. (2010) Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3. J. Mol. Catal. B: Enzym. 63, 179-187.
35. Kumar, S. (2010) Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation. Expert Opin. Drug Metab. Toxicol. 6, 115-131.
36. Gillam, E. M. J., and Hayes, M. A. (2013) The evolution of cytochrome P450 enzymes as biocatalysts in drug discovery and development. Curr. Top. Med. Chem. 13, 2254-2280.
37. O'Reilly, E., Kohler, V., and Flitsch, S. L., and Turner, N. J. (2011) Cytochromes P450 as useful biocatalysts: addressing the limitations. Chem. Commun. 47, 2490-2501.
38. Munro, A. W., and Girvan, H. M., and McLean, K. J. (2007) Cytochrome P450-redox partner fusion enzymes. Biochim. Biophys. Acta, Gen. Subj. 1770, 345-359.
39. Munro, A. W., Daff, S., Coggins, J. R., and Lindsay, J. G., and Chapman, S. K. (1996) Probing electron transfer in flavocytochrome P-450 BM3 and its component domains. Eur. J. Biochem. 239, 403-409.
40. Fisher, C. W., and Shet, M. S., Martin-Wixtrom, C., and Estabrook, R. W. (1992) High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of cytochromes P450 and NADPH-P450 reductase flavoprotein. Proc. Natl. Acad. Sci. U. S. A. 89, 10817-10821.
41. Shet, M. S., and Fisher, C. W., Arlotto, M. P., Shackleton, C. H. L., Holmans, P. L., Martin-Wixtrom, C. A., Saeki, Y., and Estabrook, R. W. (1994) Purification and enzymatic properties of a recombinant fusion protein expressed in Escherichia coli containing the domains of bovine P450 17a and rat NADPH-P450 reductase. Arch. Biochem. Biophys. 311, 402-417.
42. Shet, M. S., and Faulkner, K. M., Holmans, P. L., Fisher, C. W., and Estabrook, R. W. (1995) The effects of cytochrome b(5), NADPH-P450 reductase, and lipid on the rate of 6-beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein. Arch. Biochem. Biophys. 318, 314-321.
43. Shet, M. S., and Fisher, C. W., Holmans, P. L., and Estabrook, R. W. (1996) The omega-hydroxylation of lauric acid: Oxidation of 12-hydroxylauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase. Arch. Biochem. Biophys. 330, 199-208.
44. Deeni, Y. Y., Paine, M. J. I., Ayrton, A. D., and Clarke, S. E., Chenery, R., and Wolf, C. R. (2001) Expression, purification, and biochemical characterization of a human cytochrome P450CYP2D6-NADPH cytochrome P450 reductase fusion protein. Arch. Biochem. Biophys. 396, 16-24.
45. Inui, H., Maeda, A., and Ohkawa, H. (2007) Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-Cytochrome p450 oxidoreductase, and cytochrome b(5). Biochemistry 46, 10213-10221.
46. Helvig, C., and Capdevila, J. H. (2000) Biochemical characterization of rat P4502C11 fused to rat or bacterial NADPH-P450 reductase domains. Biochemistry 39, 5196-5205.
47. Hoffmann, S. M., and Weissenborn, M. J., Gricman, L., Notonier, S., Pleiss, J., and Hauer, B. (2016) The Impact of Linker Length on P450 Fusion Constructs: Activity, Stability and Coupling. ChemCatChem 8, 1591-1597.
48. Bakkes, P. J., Biemann, S., Bokel, A., Eickholt, M., Girhard, M., and Urlacher, V. B. (2015) Design and improvement of artificial redox modules by molecular fusion of flavodoxin and flavodoxin reductase from Escherichia coli. Sci. Rep. 5, 12158.
49. Belsare, K. D., and Ruff, A. J., Martinez, R., Shivange, A. V., Mundhada, H., Holtmann, D., Schrader, J., and Schwaneberg, U. (2014) P-Link: A method for generating multicomponent cytochrome P450 fusions with variable linker length. BioTechniques 57, 13-20.
50. Nodate, M., Kubota, M., and Misawa, N. (2006) Functional expression system for cytochrome P450 genes using the reductase domain of self-sufficient P450RhF from Rhodococcus sp NCIMB 9784. Appl. Microbiol. Biotechnol. 71, 455-462.
51. Sabbadin, F., Hyde, R., Robin, A., Hilgarth, E. M., Delenne, M., Flitsch, S., Turner, N., Grogan, G., and Bruce, N. C. (2010) LICRED: A Versatile Drop-In Vector for Rapid Generation of Redox-Self-Sufficient Cytochrome P450s. ChemBioChem 11, 987-994.
52. Schuckel, J., and Rylott, E. L., Grogan, G., and Bruce, N. C. (2012) A Gene-Fusion Approach to Enabling Plant Cytochromes P450 for Biocatalysis. ChemBioChem 13, 2758-2763.
53. Tanvir, S., Pantigny, J., Boulnois, P., and Pulvin, S. (2009) Covalent immobilization of recombinant human cytochrome CYP2E1 and glucose-6-phosphate dehydrogenase in alumina membrane for drug screening applications. J. Membr. Sci. 329, 85-90.
54. Sheldon, R. A., and van Pelt, S. (2013) Enzyme immobilisation in biocatalysis: why, what and how. Chem. Soc. Rev. 42, 6223-6235.
55. Hirakawa, H., and Nagamune, T. (2010) Molecular Assembly of P450 with Ferredoxin and Ferredoxin Reductase by Fusion to PCNA. ChemBioChem 11, 1517-1520.
56. Tan, C. Y., Hirakawa, H., and Nagamune, T. (2015) Supramolecular protein assembly supports immobilization of a cytochrome P450 monooxygenase system as water-insoluble gel. Sci. Rep. 5, 8648.
57. Tan, C. Y., Hirakawa, H., Suzuki, R., Haga, T., Iwata, F., and Nagamune, T. (2016) Immobilization of a bacterial cytochrome P450 monooxygenase system on a solid support. Angew. Chem., Int. Ed. 55, 15002-15006.
58. Lee, J. H., and Lee, S. H., Yim, S. S., Kang, K.-H., and Lee, S. Y., Park, S. J., and Jeong, K. J. (2013) Quantified High-Throughput Screening of Escherichia coli Producing Poly(3-hydroxybutyrate) Based on FACS. Appl. Biochem. Biotechnol. 170, 1767-1779.
59. Slater, S. C., and Voige, W. H., and Dennis, D. E. (1988) Cloning and expression in Escherichia coli of the Alcaligenes eutrophus H16 poly-beta-hydroxybutyrate biosynthetic pathway. J. Bacteriol. 170, 4431-4436.
60. Lee, J. H., and Nam, D. H., Lee, S. H., Park, J. H., and Park, S. J., Lee, S. H., Park, C. B., and Jeong, K. J. (2014) New Platform for Cytochrome P450 Reaction Combining in Situ Immobilization on Biopolymer. Bioconjugate Chem. 25, 2101-2104.
61. Lee, J. H., and Nam, D. H., Lee, S. H., Park, J. H., and Park, C. B., and Jeong, K. J. (2016) Solar-to-chemical conversion platform by Robust Cytochrome P450-P(3HB) complex. J. Ind. Eng. Chem. 33, 28-32.
62. Chefson, A., Zhao, J., and Auclair, K. (2006) Replacement of the natural cofactors by selected hydrogen peroxide donors or organic peroxides results in improved activity for CYP3A4 and CYP2D6. ChemBioChem 7, 916-919.
63. Ener, M. E., and Lee, Y. T., Winkler, J. R., Gray, H. B., and Cheruzel, L. (2010) Photooxidation of cytochrome P450-BM3. Proc. Natl. Acad. Sci. U. S. A. 107, 18783-18786.
64. Tran, N.-H., Nguyen, D., Dwaraknath, S., Mahadevan, S., Chavez, G., Nguyen, A., Dao, T., Mullen, S., Nguyen, T.-A., and Cheruzel, L. E. (2013) An Efficient Light-Driven P450 BM3 Biocatalyst. J. Am. Chem. Soc. 135, 14484-14487.
65. Kato, M., Nguyen, D., Gonzalez, M., Cortez, A., and Mullen, S. E., and Cheruzel, L. E. (2014) Regio- and stereoselective hydroxylation of 10-undecenoic acid with a light-driven P450 BM3 biocatalyst yielding a valuable synthon for natural product synthesis. Bioorg. Med. Chem. 22, 5687-5691.
66. Park, J. H., and Lee, S. H., Cha, G. S., Choi, D. S., and Nam, D. H., Lee, J. H., Lee, J.-K., Yun, C.-H., Jeong, K. J., and Park, C. B. (2015) Cofactor-Free Light-Driven Whole-Cell Cytochrome P450 Catalysis. Angew. Chem., Int. Ed. 54, 969-973.
67. Jensen, K., and Jensen, P. E., and Møller, B. L. (2011) Light-Driven Cytochrome P450 Hydroxylations. ACS Chem. Biol. 6, 533-539.
68. Jensen, K., and Johnston, J. B., de Montellano, P. R. O., and Moller, B. L. (2012) Photosystem I from plants as a bacterial cytochrome P450 surrogate electron donor: terminal hydroxylation of branched hydrocarbon chains. Biotechnol. Lett. 34, 239-245.
69. Wlodarczyk, A., Gnanasekaran, T., Nielsen, A. Z., and Zulu, N. N., Mellor, S. B., Luckner, M., Thofner, J. F. B., Olsen, C. E., Mottawie, M. S., Burowa, M., Pribil, M., Feussner, I., Moller, B. L., and Jensen, P. E. (2016) Metabolic engineering of light-driven cytochrome P450 dependent pathways into Synechocystis sp PCC 6803. Metab. Eng. 33, 1-11.
70. Mellor, S. B., and Nielsen, A. Z., Burow, M., Motawia, M. S., Jakubauskas, D., Møller, B. L., and Jensen, P. E. (2016) Fusion of Ferredoxin and Cytochrome P450 Enables Direct Light-Driven Biosynthesis. ACS Chem. Biol. 11, 1862-1869.
71. Ang, E. L., Zhao, H., and Obbard, J. P. (2005) Recent advances in the bioremediation of persistent organic pollutants via biomolecular engineering. Enzyme Microb. Technol. 37, 487-496.
72. Shou, M., and Korzekwa, K. R., Krausz, K. W., Crespi, C. L., and Gonzalez, F. J., and Gelboin, H. V. (1994) Regio- and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Cancer Lett. 83, 305-313.
73. Ariyoshi, N., Oguri, K., Koga, N., Yoshimura, H., and Funae, Y. (1995) Metabolism of highly persistent PCB congener, 2,4,5,2',4',5'-hexachlorobiphenyl, by human CYP2B6. Biochem. Biophys. Res. Commun. 212, 455-460.
74. Torre, C. D., Corsi, I., Alcaro, L., Amato, E., and Focardi, S. (2006) The involvement of cytochrome P450 system in the fate of 2,4,6-trinitrotoluene (TNT) in European eel [Anguilla anguilla (Linnaeus, 1758)]. Biochem. Soc. Trans. 34, 1228.
75. Rylott, E. L., and Jackson, R. G., Edwards, J., Womack, G. L., Seth-Smith, H. M., Rathbone, D. A., Strand, S. E., and Bruce, N. C. (2006) An explosive-degrading cytochrome P450 activity and its targeted application for the phytoremediation of RDX. Nat. Biotechnol. 24, 216-219.
76. Luo, A., Wu, Y.-R., Xu, Y., Kan, J., Qiao, J., Liang, L., Huang, T., and Hu, Z. (2016) Characterization of a cytochrome P450 monooxygenase capable of high molecular weight PAHs oxidization from Rhodococcus sp. P14. Process Biochem., DOI: 10.1016/j.procbio.2016.07.024.
77. Satapute, P., and Kaliwal, B. (2016) Biodegradation of the fungicide propiconazole by Pseudomonas aeruginosa PS-4 strain isolated from a paddy soil. Ann. Microbiol. 66, 1355.
78. Yang, R. S. H., and Dauterman, W. C., and Hodgson, E. (1969) Enzymatic degradation of diazinon by rat liver microsomes. Life Sci. 8, 667-672.
79. Sakaki, T., Shinkyo, R., Takita, T., Ohta, M., and Inouye, K. (2002) Biodegradation of polychlorinated dibenzo-p-dioxins by recombinant yeast expressing rat CYP1A subfamily. Arch. Biochem. Biophys. 401, 91-98.
80. Jung, J., Philippot, L., and Park, W. (2016) Metagenomic and functional analyses of the consequences of reduction of bacterial diversity on soil functions and bioremediation in diesel-contaminated microcosms. Sci. Rep. 6, 23012.
81. Yergeau, E., Sanschagrin, S., Beaumier, D., and Greer, C. W. (2012) Metagenomic Analysis of the Bioremediation of Diesel-Contaminated Canadian High Arctic Soils. PLoS One 7, e30058.
82. Alagic, S. C., Jovanovic, V. P. S., Mitic, V. D., and Cvetkovic, J. S., Petrovic, G. M., and Stojanovic, G. S. (2016) Bioaccumulation of HMW PAHs in the roots of wild blackberry from the Bor region (Serbia): Phytoremediation and biomonitoring aspects. Sci. Total Environ. 562, 561-570.
83. Best, E. P. H., and Sprecher, S. L., Larson, S. L., Fredrickson, H. L., and Bader, D. F. (1999) Environmental behavior of explosives in groundwater from the Milan Army Ammunition Plant in aquatic and wetland plant treatments. Uptake and fate of TNT and RDX in plants. Chemosphere 39, 2057-2072.
84. Inui, H., Ueyama, Y., Shiota, N., Okhawa, Y., and Ohkawa, H. (1999) Herbicide metabolism and cross-tolerance in transgenic potato plants expressing human CYP1A1. Pestic. Biochem. Physiol. 64, 33-46.
85. Lacour, T., and Ohkawa, H. (1999) Engineering and biochemical characterization of the rat microsomal cytochrome P4501A1 fused to ferredoxin and ferredoxin-NADP(+) reductase from plant chloroplasts. Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 1433, 87-102.
86. Inui, H., Kodama, T., Ohkawa, Y., and Ohkawa, H. (2000) Herbicide metabolism and cross-tolerance in transgenic potato plants co-expressing human CYP1A1, CYP2B6, and CYP2C19. Pestic. Biochem. Physiol. 66, 116-129.
87. Inui, H., Shiota, N., Motoi, Y., Ido, Y., Inoue, T., Kodama, T., Ohkawa, Y., and Ohkawa, H. (2001) Metabolism of herbicides and other chemicals in human cytochrome P450 species and in transgenic potato plants co-expressing human CYP1A1, CYP2B6 and CYP2C19. J. Pestic. Sci. 26, 28-40.
88. Hirose, S., Kawahigashi, H., Ozawa, K., Shiota, N., Inui, H., Ohkawa, H., and Ohkawa, Y. (2005) Transgenic rice containing human CYP2B6 detoxifies various classes of herbicides. J. Agric. Food Chem. 53, 3461-3467.
89. Kawahigashi, H., Hirose, S., Ohkawa, H., and Ohkawa, Y. (2005) Phytoremediation of metolachlor by transgenic rice plants expressing human CYP2B6. J. Agric. Food Chem. 53, 9155-9160.
90. Kawahigashi, H., Hirose, S., Ohkawa, H., and Ohkawa, Y. (2005) Transgenic rice plants expressing human CYP1A1 remediate the triazine herbicides atrazine and simazine. J. Agric. Food Chem. 53, 8557-8564.
91. Rylott, E. L., and Budarina, M. V., Barker, A., Lorenz, A., Strand, S. E., and Bruce, N. C. (2011) Engineering plants for the phytoremediation of RDX in the presence of the co-contaminating explosive TNT. New Phytol. 192, 405-413.
92. Li, Q. S., Ogawa, J., Schmid, R. D., and Shimizu, S. (2001) Engineering cytochrome P450 BM-3 for oxidation of polycyclic aromatic hydrocarbons. Appl. Environ. Microbiol. 67, 5735-5739.
93. Syed, K., Porollo, A., Miller, D., and Yadav, J. S. (2013) Rational engineering of the fungal P450 monooxygenase CYP5136A3 to improve its oxidizing activity toward polycyclic aromatic hydrocarbons. Protein Eng., Des. Sel. 26, 553-557.
94. Jones, J. P., O'Hare, E. J., and Wong, L. L. (2001) Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cyto-chrome P450cam). Eur. J. Biochem. 268, 1460-1467.
95. Dennig, A., Lulsdorf, N., Liu, H., and Schwaneberg, U. (2013) Regioselective o-Hydroxylation of Monosubstituted Benzenes by P450 BM3. Angew. Chem., Int. Ed. 52, 8459-8462.
96. Gredell, J. A., and Frei, C. S., and Cirino, P. C. (2012) Protein and RNA engineering to customize microbial molecular reporting. Biotechnol. J. 7, 477-499.
97. Shumyantseva, V. V., and Bulko, T. V., Kuznetsova, G. P., Samenkova, N. F., and Archakov, A. I. (2009) Electrochemistry of cytochromes P450: Analysis of current-voltage characteristics of electrodes with immobilized cytochromes P450 for the screening of substrates and inhibitors. Biochemistry (Moscow) 74, 438-444.
98. Lu, J. S., and Cui, D. M., Li, H. N., Zhang, Y. J., and Liu, S. Q. (2015) Cytochrome P450 bienzymes assembled on Au/chitosan/reduced graphene oxide nanosheets for electrochemically-driven drug cascade metabolism. Electrochim. Acta 165, 36-44.
99. Xue, Q., Kato, D., Kamata, T., Guo, Q. H., and You, T. Y., and Niwa, O. (2013) Human cytochrome P450 3A4 and a carbon nanofiber modified film electrode as a platform for the simple evaluation of drug metabolism and inhibition reactions. Analyst 138, 6463-6468.
100. Dai, C. Y., and Ding, Y. L., Li, M., and Fei, J. J. (2012) Direct electrochemistry of cytochrome P450 in a biocompatible film composed of an epoxy polymer and acetylene black. Microchim. Acta 176, 397-404.
101. Xu, X., Wei, W., Huang, M. H., Yao, L., and Liu, S. Q. (2012) Electrochemically driven drug metabolism via cytochrome P450 2C9 isozyme microsomes with cytochrome P450 reductase and indium tin oxide nanoparticle composites. Chem. Commun. 48, 7802-7804.
102. Llaudet, E. C., Darimont, D., Samba, R., Matiychyn, I., Stelzle, M., Weissenborn, M. J., and Hauer, B. (2016) Expanding an Efficient, Electrically Driven and CNT-Tagged P450 System into the Third Dimension: A Nanowired CNT-Containing and Enzyme-Stabilising 3D Sol-Gel Electrode. ChemBioChem 17, 1367-1373.
103. Mie, Y., Suzuki, M., and Komatsu, Y. (2009) Electrochemically Driven Drug Metabolism by Membranes Containing Human Cytochrome P450. J. Am. Chem. Soc. 131, 6646-6647.
104. Krishnan, S., Wasalathanthri, D., Zhao, L. L., and Schenkman, J. B., and Rusling, J. F. (2011) Efficient Bioelectronic Actuation of the Natural Catalytic Pathway of Human Metabolic Cytochrome P450s. J. Am. Chem. Soc. 133, 1459-1465.
105. Hvastkovs, E. G., and Rusling, J. F. (2016) State-of-the-Art Metabolic Toxicity Screening and Pathway Evaluation. Anal. Chem. 88, 4584-4599.
106. Hvastkovs, E. G., and Schenkman, J. B., and Rusling, J. F. (2012) Metabolic Toxicity Screening Using Electrochemiluminescence Arrays Coupled with Enzyme-DNA Biocolloid Reactors and Liquid Chromatography-Mass Spectrometry, in Annual Review of Analytical Chemistry (Cooks, R. G., and Yeung, E. S., Eds.) Vol. 5, pp 79-105, Annual Reviews, Palo Alto, CA
107. Schneider, E., and Clark, D. S. (2013) Cytochrome P450 (CYP) enzymes and the development of CYP biosensors. Biosens. Bioelectron. 39, 1-13.
108. Bistolas, N, Wollenberger, U., Jung, C, and Scheller, F. W. (2005) Cytochrome P450 biosensors - a review. Biosens. Bioelectron. 20, 2408-2423.
109. Campas, M., Prieto-Simon, B., and Marty, J.-L. (2009) A review of the use of genetically engineered enzymes in electrochemical biosensors. Semin. Cell Dev. Biol. 20, 3-9.
110. Ross, N., Hendricks-Leukes, N., Ajayi, R. F., Baker, P., and Iwuoha, E. I. (2015) Conductive Composite Biosensor System for Electrochemical Indinavir Drug Detection. J. Chem. 2015, 1-7.
111. Ignaszak, A, Hendricks, N, Waryo, T., Songa, E., Jahed, N, Ngece, R, Al-Ahmed, A., Kgarebe, B., Baker, P., and Iwuoha, E. I. (2009) Novel therapeutic biosensor for indinavir-A protease inhibitor antiretroviral drug. J. Pharm. Biomed. Anal. 49, 498-501.
112. Muller, M., Agarwal, N, and Kim, J. (2016) A Cytochrome P450 3A4 Biosensor Based on Generation 4.0 PAMAM Dendrimers for the Detection of Caffeine. Biosensors 6, 44.
113. Asturias-Arribas, L., Alonso-Lomillo, M. A., Dominguez-Renedo, O., and Arcos-Martinez, M. J. (2014) Cytochrome P450 2D6 based electrochemical sensor for the determination of codeine. Talanta 129, 315-319.
114. Baj-Rossi, C., Jost, T. R, Cavallini, A., Grassi, F., De Micheli, G., and Carrara, S. (2014) Continuous monitoring of Naproxen by a cytochrome P450-based electrochemical sensor. Biosens. Bioelectron. 53, 283-287.
115. Ngece, R. F., West, N, and Ndangili, P. M., Olowu, R. A., Williams, A., Hendricks, N., Mailu, S., Baker, P., and Iwuoha, E. (2011) A silver Nanoparticle/Poly (8-Anilino-1-Naphthalene Sulphonic Acid) Bio-electrochemical Biosensor System for the Analytical Determination of Ethambutol. Int. J. Electrochem. Sci. 6, 1820-1834.
116. Alonso-Lomillo, M. A., Gonzalo-Ruiz, J., Dominguez-Renedo, O., Munoz, F., and Arcos-Martinez, M. J. (2008) CYP450 biosensors based on gold chips for antiepileptic drugs determination. Biosens. Bioelectron. 23, 1733-1737.
117. Iwuoha, E., Ngece, R., Klink, M., and Baker, P. (2007) Amperometric responses of CYP2D6 drug metabolism nanobiosensor for sertraline: a selective serotonin reuptake Inhibitor. IET Nanobiotechnol. 1, 62-67.
118. Asturias-Arribas, L., Alonso-Lomillo, M. A., Dominguez-Renedo, O., and Arcos-Martinez, M. J. (2013) Electrochemical determination of cocaine using screen-printed cytochrome P450 2B4 based biosensors. Talanta 105, 131-134.
119. Asturias-Arribas, L., Alonso-Lomillo, M. A., Dominguez-Renedo, O., and Arcos-Martinez, M. J. (2011) CYP450 biosensors based on screen-printed carbon electrodes for the determination of cocaine. Anal. Chim. Acta 685, 15-20.
120. Sun, P. Y., and Wu, Y. H. (2013) An amperometric biosensor based on human cytochrome P450 2C9 in polyacrylamide hydrogel films for bisphenol A determination. Sens. Actuators, B 178, 113-118.
121. Hendricks, N. R., and Waryo, T. T., Arotiba, O., Jahed, N, Baker, P. G. L., and Iwuoha, E. I. (2009) Mcrosomal cytochrome P450-3A4 (CYP3A4) nanobiosensor for the determination of 2,4-dichlorophenol-An endocrine disruptor compound. Electrochim. Acta 54, 1925-1931.
122. Wu, Y. H. (2011) Direct electrochemistry of cytochrome P450 6A1 in mimic bio-membrane and its application for pesticides sensing. Sens. Actuators, B 156, 773-778.
123. Wu, Y. H., and Liu, X. Q., Zhang, L., and Wang, C. T. (2011) An amperometric biosensor based on rat cytochrome P450 1A1 for benzo a pyrene determination. Biosens. Bioelectron. 26, 2177-2182.
124. Jalalvand, A. R., and Gholivand, M. B., Goicoechea, H. C., Skov, T., and Mansouri, K. (2015) Mimicking enzymatic effects of cytochrome P450 by an efficient biosensor for in vitro detection of DNA damage. Int. J. Biol. Macromol. 79, 1004-1010.
125. Kumar, S., Zhao, Y., Sun, L., Negi, S. S., and Halpert, J. R., and Muralidhara, B. K. (2007) Rational engineering of human cytochrome P450 2B6 for enhanced expression and stability: Importance of a Leu(264)-> Phe substitution. Mol. Pharmacol. 72, 1191-1199.
126. Yoetz-Kopelman, T., Porat-Ophir, C., Shacham-Diamand, Y., and Freeman, A. (2016) Whole-cell amperometric biosensor for screening of cytochrome P450 inhibitors. Sens. Actuators, B 223, 392-399.
127. Archakov, A. I., and Ivanov, Y. D. (2002) Optical biosensor and scanning probe microscopy studies of cytochrome P450 interactions with redox partners and phospholipid layers. Methods Enzymol. 357, 94-103.
128. Plucinski, L., and Gartia, M. R., Arnold, W. R., Ameen, A., Chang, T. W., Hsiao, A., and Liu, G. L., and Das, A. (2016) Substrate binding to cytochrome P450-2J2 in Nanodiscs detected by nanoplasmonic Lycurgus cup arrays. Biosens. Bioelectron. 75, 337-346.
129. Chang, G., Mori, Y., Mori, S., Irie, T., Nagai, H., Goto, T., Tatsu, Y., Imaishi, H., and Morigaki, K. (2012) Microarray of Human P450 with an Integrated Oxygen Sensing Film for High-Throughput Detection of Metabolic Activities. Anal. Chem. 84, 5292-5297.
130. Chang, G., Morigaki, K., Tatsu, Y., Hikawa, T., Goto, T., and Imaishi, H. (2011) Vertically Integrated Human P450 and Oxygen Sensing Film for the Assays of P450 Metabolic Activities. Anal. Chem. 83, 2956-2963.
131. Siedler, S., Schendzielorz, G., Binder, S., Eggeling, L., Bringer, S., and Bott, M. (2014) SoxR as a Single-Cell Biosensor for NADPH-Consuming Enzymes in Escherichia coli. ACS Synth. Biol. 3, 41-47.
132. Khalil, A. S., and Collins, J. J. (2010) Synthetic biology: applications come of age. Nat. Rev. Genet. 11, 367-379.
133. Hung, K. W. V., Suen, M. F. K., Chen, Y. F., and Cai, H. B., Mo, Z. X., and Yung, K. K. L. (2012) Detection of water toxicity using cytochrome P450 transgenic zebrafish as live biosensor: For polychlorinated biphenyls toxicity. Biosens. Bioelectron. 31, 548-553.
134. Shimada, T., Oda, Y., Yamazaki, H., Mimura, M., and Guengerich, F. P. (1994) SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009 Methods in Molecular Genetics, Gene and Chromosome Analysis (Adolph, K. W., Ed.) Vol. 5, pp 342-355, Academic Press, Orlando, FL.
135. Oda, Y., Nakamura, S.-i., Oki, I., Kato, T., and Shinagawa, H. (1985) Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat. Res. 147, 219-229.
136. Aryal, P., Yoshikawa, K., Terashita, T., Guengerich, F. P., Shimada, T., and Oda, Y. (1999) Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 442, 113-120.
137. Oda, Y., Aryal, P., Terashita, T., Gillam, E. M. J., Guengerich, F. P., and Shimada, T. (2001) Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 492, 81-90.
138. Prosser, G. A., and Patterson, A. V., and Ackerley, D. F. (2010) uvrB gene deletion enhances SOS chromotest sensitivity for nitroreductases that preferentially generate the 4-hydroxylamine metabolite of the anti-cancer prodrug CB1954. J. Biotechnol. 150, 190-194.
139. Kotova, V. Y., and Manukhov, I. V., and Zavilgelskii, G. B. (2010) Lux-biosensors for detection of SOS-response, heat shock, and oxidative stress. Appl. Biochem. Microbiol. 46, 781-788.
140. Chen, Z., Lu, M., Zou, D., and Wang, H. (2012) An E. coli SOS-EGFP biosensor for fast and sensitive detection of DNA damaging agents. J. Environ. Sci. 24, 541-549.
141. Kostrzynska, M., and Leung, K. T., Lee, H., and Trevors, J. T. (2002) Green fluorescent protein-based biosensor for detecting SOS-inducing activity of genotoxic compounds. J. Microbiol. Methods 48, 43-51.
142. Copp, J. N., and Williams, E. M., Rich, M. H., Patterson, A. V., and Smaill, J. B., and Ackerley, D. F. (2014) Toward a high-throughput screening platform for directed evolution of enzymes that activate genotoxic prodrugs. Protein Eng., Des. Sel. 27, 399-403.
143. Wei, T., Zhang, C., Xu, X., Hanna, M., and Zhang, X. H., Wang, Y., Dai, H. P., and Xiao, W. (2013) Construction and evaluation of two biosensors based on yeast transcriptional response to genotoxic chemicals. Biosens. Bioelectron. 44, 138-145.
144. Hastwell, P. W., and Chai, L. L., Roberts, K. J., Webster, T. W., and Harvey, J. S., Rees, R. W., and Walmsley, R. M. (2006) High-speciticity and high-sensitivity genotoxicity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 607, 160-175.
145. Ohno, K., Ishihata, K., Tanaka-Azuma, Y., and Yamada, T. (2008) A genotoxicity test system based on p53R2 gene expression in human cells: Assessment of its reactivity to various classes of genotoxic chemicals. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 656, 27-35.
146. Westerink, W. M. A., Stevenson, J. C. R., Horbach, G. J., and Schoonen, W. (2010) The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 696, 21-40.
147. Zager, V., Cemazar, M., Hreljac, I., Lah, T. T., Sersa, G., and Filipic, M. (2010) Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression. Radiol. Oncol. 44, 42-51.
148. Hendriks, G., Atallah, M., Raamsman, M., Morolli, B., van der Putten, H., Jaadar, H., Tijdens, I., Esveldt-van Lange, R., Mullenders, L., van de Water, B., and Vrieling, H. (2011) Sensitive DsRed fluorescence-based reporter cell systems for genotoxicity and oxidative stress assessment. Mutat. Res., Fundam. Mol. Mech. Mutagen. 709-10, 49-59.
149. Hendriks, G., Atallah, M., Morolli, B., Calleja, F., Ras-Verloop, N., Huijskens, I., Raamsman, M., van de Water, B., and Vrieling, H. (2012) The ToxTracker Assay: Novel GFP Reporter Systems that Provide Mechanistic Insight into the Genotoxic Properties of Chemicals. Toxicol. Sci. 125, 285-298.
150. Hughes, C., Rabinowitz, A., Tate, M., Birrell, L., Allsup, J., Billinton, N., and Walmsley, R. M. (2012) Development of a High-Throughput Gaussia Luciferase Reporter Assay for the Activation of the GADD45a Gene by Mutagens, Promutagens, Clastogens, and Aneugens. J. Biomol. Screening 17, 1302-1315.
151. Blagus, T., Zager, V., Cemazar, M., Sersa, G., Kamensek, U., Zegura, B., Nunic, J., and Filipic, M. (2014) A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents. Biosens. Bioelectron. 61, 102-111.
152. Ireno, I. C., Baumann, C., Stober, R., Hengstler, J. G., and Wiesmuller, L. (2014) Fluorescence-based recombination assay for sensitive and specific detection of genotoxic carcinogens in human cells. Arch. Toxicol. 88, 1141-1159.
153. van der Linden, S. C., von Bergh, A. R. M., van Vught-Lussenburg, B. M. A., Jonker, L. R. A., Teunis, M., Krul, C. A. M., and van der Burg, B. (2014) Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 760, 23-32.
154. Hendriks, G., and Derr, R. S., Misovic, B., Morolli, B., Calleja, F., and Vrieling, H. (2016) The Extended ToxTracker Assay Discriminates Between Induction of DNA Damage, Oxidative Stress, and Protein Misfolding. Toxicol. Sci. 150, 190-203.
155. Luzy, A. P., Orsini, N., Linget, J. M., and Bouvier, G. (2013) Evaluation of the GADD45 alpha-GFP GreenScreen HC assay for rapid and reliable in vitro early genotoxicity screening. J. Appl. Toxicol. 33, 1303-1315.
156. Topham, C., Hastwell, P., and Walmsley, R. (2007) A comparative study into the high specificity of GreenScreen HC in relation to other in-vitro genotoxicity tests in the human lymphoblastoid cell line TK6. Mutagenesis 22, 452-453.
157. Billinton, N., and Hastwell, P. W., Beerens, D., Birrell, L., Ellis, P., Maskell, S., Webster, T. W., Windebank, S., Woestenborghs, F., Lynch, A. M., Scott, A. D., Tweats, D. J., van Gompel, J., Rees, R. W., and Walmsley, R. M. (2008) Interlaboratory assessment of the Green-Screen HC GADD45a-GFP genotoxicity screening assay: An enabling study for independent validation as an alternative method. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 653, 23-33.
158. Hastwell, P. W., and Dilmamode, B. Z., Powney, B. L., Brown, A. J., and Harvey, J. S., Lynch, A. M., Rees, R. W., and Rees, S. (2009) Incorporation of the GADD45-GFP greenscreen HC assay into pre-clinical drug development screening to reduce compound attrition. Mutagenesis 24, 549-549.
159. Knight, A. W., Little, S., Houck, K., Dix, D., Judson, R., Richard, A., McCarroll, N., Akerman, G., Yang, C. H., Birrell, L., and Walmsley, R. M. (2009) Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast (TM) chemicals. Regul. Toxicol. Pharmacol. 55, 188-199.
160. Billinton, N., Bruce, S., Hansen, J. R., and Hastwell, P. W., Jagger, C., McComb, C., Klug, M. L., Pant, K., Rabinowitz, A., Rees, R., Tate, M., Vinggaard, A. M., and Walmsley, R. M. (2010) A pre-validation transferability study of the Green Screen HC GADD45a-GFP assay with a metabolic activation system (S9). Mutat. Res., Genet. Toxicol. Environ. Mutagen. 700, 44-50.
161. Hendriks, G., van de Water, B., Schoonen, W., and Vrieling, H. (2013) Cellular-signaling pathways unveil the carcinogenic potential of chemicals. J. Appl. Toxicol. 33, 399-409.
162. Vinken, M. (2013) The adverse outcome pathway concept: A pragmatic tool in toxicology. Toxicology 312, 158-165.
163. Persson, M., and Loye, A. F., Mow, T., and Hornberg, J. J. (2013) A high content screening assay to predict human drug-induced liver injury during drug discovery. J. Pharmacol. Toxicol. Methods 68, 302-313.
164. Garside, H., and Marcoe, K. F., Chesnut-Speelman, J., Foster, A. J., Muthas, D., and Kenna, J. G., Warrior, U., Bowes, J., and Baumgartner, J. 2014. Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes. Toxicol. In Vitro 28, 171-181.
165. O'Brien, P. J. (2014) High-Content Analysis in Toxicology: Screening Substances for Human Toxicity Potential, Elucidating Subcellular Mechanisms and In Vivo Use as Translational Safety Biomarkers. Basic Clin. Pharmacol. Toxicol. 115, 4-17.
166. Naoghare, P. K., and Kim, M. J., and Song, J. M. (2008) Uniform threshold intensity distribution-based quantitative multivariate imaging cytometry. Anal. Chem. 80, 5407-5417.
167. Zhang, Q., Bhattacharya, S., Conolly, R. B., and Clewell, H. J., Kaminski, N. E., and Andersen, M. E. (2014) Molecular Signaling Network Motifs Provide a Mechanistic Basis for Cellular Threshold Responses. Environ. Health Perspect. 122, 1261-1270.
168. Trosset, J. Y., and Carbonell, P. (2015) Synthetic biology for pharmaceutical drug discovery. Drug Des., Dev. Ther. 9, 6285-6302.
169. Anderson, J. C., and Voigt, C. A., and Arkin, A. P. (2007) Environmental signal integration by a modular AND gate. Mol. Syst. Biol., Vol. 3, DOI: 10.1038/msb4100173.
170. Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., and Hughes, S. H., and Chatterjee, D. K. (2011) Protein delivery using engineered viruslike particles. Proc. Natl. Acad. Sci. U. S. A. 108, 16998-17003.
171. Uchida, M., LaFrance, B., Broomell, C. C., and Prevelige, P. E., and Douglas, T. (2015) Higher Order Assembly of Virus-like Particles (VLPs) Mediated by Multi-valent Protein Linkers. Small 11, 1562-1570.
172. Ye, H. F., Daoud-El Baba, M., Peng, R. W., and Fussenegger, M. (2011) A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice. Science 332, 1565-1568.
173. Ye, H. F., Charpin-El Hamri, G., Zwicky, K., Christen, M., Folcher, M., and Fussenegger, M. (2013) Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc. Natl. Acad. Sci. U. S. A. 110, 141-146.
174. Weber, W., and Fussenegger, M. (2012) Emerging biomedical applications of synthetic biology. Nat. Rev. Genet. 13, 21-35.
175. Erkelenz, M., and Kuo, C. H., and Niemeyer, C. M. (2011) DNAMediated Assembly of Cytochrome P450 BM3 Subdomains. J. Am. Chem. Soc. 133, 16111-16118.
176. Ichinose, H., Hatakeyama, M., and Yamauchi, Y. (2015) Sequence modifications and heterologous expression of eukaryotic cytochromes P450 in Escherichia coli. J. Biosci. Bioeng. 120, 268-274.
177. Nielsen, A. A. K., Segall-Shapiro, T. H., and Voigt, C. A. (2013) Advances in genetic circuit design: novel biochemistries, deep part mining, and precision gene expression. Curr. Opin. Chem. Biol. 17, 878-892.